CoChat

Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis

Open access
Fernandez-Marcos, Pablo J., Jeninga, Ellen H., Canto, Carles, Harach, Taoufiq, de Boer, Vincent C. J., Andreux, Penelope, Moullan, Norman, Pirinen, Eija, Yamamoto, Hiroyasu, Houten, Sander M., Schoonjans, Kristina, Auwerx, Johan · 2012 · Scientific Reports

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Sirt3 is a mitochondrial sirtuin, predominantly expressed in highly metabolic tissues. Germline ablation of Sirt3 has major metabolic consequences, including increased susceptibility to metabolic damage and oxidative stress after high fat feeding. In order to determine the contribution of liver and skeletal muscle to these phenotypes, we generated muscle-specific Sirt3 (Sirt3(skm-/-)) and liver-specific Sirt3 (Sirt3(hep-/-)) knock-out mice. Despite a marked global hyperacetylation of mitochondrial proteins, Sirt3(skm-/-) and Sirt3(hep-/-) mice did not manifest any overt metabolic phenotype under either chow or high fat diet conditions. Similarly, there was no evidence for increased oxidative stress in muscle or liver when Sirt3 was ablated in a tissue-specific manner. These observations suggest that the mitochondrial hyperacetylation induced by Sirt3-deletion in a tissue specific manner is not necessarily linked to mitochondrial dysfunction and does not recapitulate the metabolic abnormalities observed in the germline Sirt3 knock-out mice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep00425

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Generation, validation and expression of metabolic genes for the Sirt3hep−/− and Sirt3skm−/− mice. (A) Targeting strategy used to generate the tissue-specific Sirt3-deficient mice. Maps of the Sirt3 genomic locus showing the conditional allele (upper panel) and the KO allele (lower panel). The white arrowheads indicate the LoxP sites and the black vertical bars represent the respective exons. (B–C) Sirt3 mRNA expression levels in different tissues of Sirt3skm+/+ and Sirt3skm−/− mice (B) and of Sirt3hep+/+ and Sirt3hep−/− mice (C); n = 4 per group. (D–E) Sirt3 protein expression as assessed by western blotting in muscle (D) and liver (E) of the Sirt3-deficient mouse models. Porin is used as a loading control. (F–G) Gene expression in gastrocnemius muscle of Sirt3skm+/+ and Sirt3skm−/− mice (F) and in liver of Sirt3hep+/+ and Sirt3hep−/− mice (G) after 18 weeks of HFD. mRNA levels were normalized to 36B4. Data represent the mean ± SEM for at least four animals per group.
Figure 1 Generation, validation and expression of metabolic genes for the Sirt3hep−/− and Sirt3skm−/− mice. (A) Targeting strategy used to generate the tissue-specific Sirt3-deficient mice. Maps of the Sirt3 genomic locus showing the conditional allele (upper panel) and the KO allele (lower panel). The white arrowheads indicate the LoxP sites and the black vertical bars represent the respective exons. (B–C) Sirt3 mRNA expression levels in different tissues of Sirt3skm+/+ and Sirt3skm−/− mice (B) and of Sirt3hep+/+ and Sirt3hep−/− mice (C); n = 4 per group. (D–E) Sirt3 protein expression as assessed by western blotting in muscle (D) and liver (E) of the Sirt3-deficient mouse models. Porin is used as a loading control. (F–G) Gene expression in gastrocnemius muscle of Sirt3skm+/+ and Sirt3skm−/− mice (F) and in liver of Sirt3hep+/+ and Sirt3hep−/− mice (G) after 18 weeks of HFD. mRNA levels were normalized to 36B4. Data represent the mean ± SEM for at least four animals per group.CC BY-NC-ND · PubMed Central
Figure 2 Metabolic phenotyping of Sirt3hep−/− mice. (A) Experimental schedule of the clinical phenotyping protocol. MCB: non-invasive monitoring of body fat and lean mass by EchoMRI, energy expenditure by indirect calorimetry (CLAMS system), and blood sampling for metabolite analysis; I: intra-peritoneal glucose tolerance test (ipGTT); T: intra-peritoneal insulin tolerance test (ipITT); †: sacrifice and collection of blood and organs for further analysis. (B) Body weight and (C) body composition of Sirt3hep+/+ and Sirt3hep−/− mice before and after 8 weeks of HFD. (D–G) Daily food intake (D), mean O2 consumption (VO2; E), mean respiratory exchange ratio (RER; F) and total ambulatory locomotor activity (G) as measured over a 24 h period before and after HFD. (H) Relative weight of tissues normalized by body weight in Sirt3hep+/+ and Sirt3hep−/− mice. (I–J) Intra-peritoneal glucose tolerance test (ipGTT; I), and intra-peritoneal insulin tolerance test (ipITT; J) in mice fed a HFD for 15-17 weeks. The bar graphs represent the average area under the curve (AUC). (K) Levels of the indicated aminoacids were determined in plasma from 8 weeks old male mice. (L) β-hydroxy-butyrate was analysed in plasma from 8 weeks old male mice before and after a 24h fasting period. (M) Acylcarnitine levels in plasma from 8 weeks old male mice. Results are represented as mean values (n = 8−10 mice for each group) ± standard error of the mean (SEM).
Figure 2 Metabolic phenotyping of Sirt3hep−/− mice. (A) Experimental schedule of the clinical phenotyping protocol. MCB: non-invasive monitoring of body fat and lean mass by EchoMRI, energy expenditure by indirect calorimetry (CLAMS system), and blood sampling for metabolite analysis; I: intra-peritoneal glucose tolerance test (ipGTT); T: intra-peritoneal insulin tolerance test (ipITT); †: sacrifice and collection of blood and organs for further analysis. (B) Body weight and (C) body composition of Sirt3hep+/+ and Sirt3hep−/− mice before and after 8 weeks of HFD. (D–G) Daily food intake (D), mean O2 consumption (VO2; E), mean respiratory exchange ratio (RER; F) and total ambulatory locomotor activity (G) as measured over a 24 h period before and after HFD. (H) Relative weight of tissues normalized by body weight in Sirt3hep+/+ and Sirt3hep−/− mice. (I–J) Intra-peritoneal glucose tolerance test (ipGTT; I), and intra-peritoneal insulin tolerance test (ipITT; J) in mice fed a HFD for 15-17 weeks. The bar graphs represent the average area under the curve (AUC). (K) Levels of the indicated aminoacids were determined in plasma from 8 weeks old male mice. (L) β-hydroxy-butyrate was analysed in plasma from 8 weeks old male mice before and after a 24h fasting period. (M) Acylcarnitine levels in plasma from 8 weeks old male mice. Results are represented as mean values (n = 8−10 mice for each group) ± standard error of the mean (SEM).CC BY-NC-ND · PubMed Central
Figure 3 Metabolic phenotyping of Sirt3skm−/− mice. (A) Experimental schedule of the clinical phenotyping protocol. For abbreviations see legend of Fig. 2A; E: endurance exercise on a treadmill; N: non-invasive blood pressure measurement (NIBP); C: cold test. (B) Body weight and (C) body composition of Sirt3skm+/+ and Sirt3skm−/− mice before and after 8 weeks of HFD. (D–G) Daily food intake (D), mean O2 consumption (VO2; E), mean respiratory exchange ratio (RER; F) and total ambulatory locomotor activity (G) as measured over a 24 h period before and after HFD. (H) Relative weight of tissues normalized by body weight in Sirt3skm+/+ and Sirt3skm−/− mice. (I) Intra-peritoneal glucose tolerance test (ipGTT, left panel) and plasma insulin during ipGTT (right panel) in mice fed a HFD for 16 weeks. (J) Intra-peritoneal insulin tolerance test (ipITT) in Sirt3skm+/+ and Sirt3skm−/− mice fed a HFD for 17 weeks. (I and J) The bar graph (inner panels) represents the average area under the curve (AUC). (K) Sirt3skm+/+ and Sirt3skm−/− mice fasted for 24h were exposed to 4°C for 6 h and rectal temperature was monitored. (L) Endurance exercise test on Sirt3skm+/+ and Sirt3skm−/− mice before and after 12 weeks of HFD. (M) Heart rate and (N) systolic blood pressure were measured in Sirt3skm+/+ and Sirt3skm−/− mice after 10 weeks on HFD. Results are presented as mean values (n = 8−10 mice for each group) ± SEM.
Figure 3 Metabolic phenotyping of Sirt3skm−/− mice. (A) Experimental schedule of the clinical phenotyping protocol. For abbreviations see legend of Fig. 2A; E: endurance exercise on a treadmill; N: non-invasive blood pressure measurement (NIBP); C: cold test. (B) Body weight and (C) body composition of Sirt3skm+/+ and Sirt3skm−/− mice before and after 8 weeks of HFD. (D–G) Daily food intake (D), mean O2 consumption (VO2; E), mean respiratory exchange ratio (RER; F) and total ambulatory locomotor activity (G) as measured over a 24 h period before and after HFD. (H) Relative weight of tissues normalized by body weight in Sirt3skm+/+ and Sirt3skm−/− mice. (I) Intra-peritoneal glucose tolerance test (ipGTT, left panel) and plasma insulin during ipGTT (right panel) in mice fed a HFD for 16 weeks. (J) Intra-peritoneal insulin tolerance test (ipITT) in Sirt3skm+/+ and Sirt3skm−/− mice fed a HFD for 17 weeks. (I and J) The bar graph (inner panels) represents the average area under the curve (AUC). (K) Sirt3skm+/+ and Sirt3skm−/− mice fasted for 24h were exposed to 4°C for 6 h and rectal temperature was monitored. (L) Endurance exercise test on Sirt3skm+/+ and Sirt3skm−/− mice before and after 12 weeks of HFD. (M) Heart rate and (N) systolic blood pressure were measured in Sirt3skm+/+ and Sirt3skm−/− mice after 10 weeks on HFD. Results are presented as mean values (n = 8−10 mice for each group) ± SEM.CC BY-NC-ND · PubMed Central
Figure 4 Hyperacetylation of mitochondrial proteins but normal ROS markers in Sirt3hep−/− and Sirt3skm−/− mice subjected to HFD. (A) Protein expression levels of complex I, II, IV and V in isolated mitochondria of Sirt3skm+/+ and Sirt3skm−/− muscle (left panels) and Sirt3hep+/+ and Sirt3hep−/− livers (right panels). (B, C) Acetylation status of mitochondrial proteins extracted from muscle and liver of Sirt3skm+/+ and Sirt3skm−/− mice (B) and Sirt3hep+/+ and Sirt3hep−/− mice (C). Mitochondrial protein lysates were subjected to western blotting using an anti-acetylated lysine antibody (Ac-K) and porin as a loading control. (D) Acetylation level of complex I members (top two rows of panels) and Sod2 (bottom two rows of panels) in Sirt3skm+/+ and Sirt3skm−/− muscle (left panels) or Sirt3hep+/+ and Sirt3hep−/− livers (right panels). Endogenous Ndufa9 or Sod2 were immunopurified from muscle lysates and immunoblotted using Ndufa9/Sod2 and Ac-K antibodies. (E) Complex I (CI), complex IV (CIV) and Citrate synthase (CS) activities in Sirt3skm+/+ and Sirt3skm−/− muscle (left panel) or Sirt3hep+/+ and Sirt3hep−/− (right panel). (F) Oxygen consumption rate (OCR) from primary hepatocytes obtained from Sirt3L2/L2 mice infected with the indicated viruses. (G) ATP levels were measured from the indicated tissue lysates. (H–K) Activities of mitochondrial Sod2 (H) and catalase (I) and levels of 4-hydroxy-2-nonenal (HNE; J) and GSH/GSSG ratio (K) in muscle and liver lysates of Sirt3skm+/+ and Sirt3skm−/− mice (left panels) or Sirt3hep+/+ and Sirt3hep−/− mice (right panels). Measurements in panels E–K were determined using samples from at least four mice per genotype. All the samples used for these studies come from mice subjected to the HFD treatment, sacrificed in fed state. Data are represented as mean ± SEM.
Figure 4 Hyperacetylation of mitochondrial proteins but normal ROS markers in Sirt3hep−/− and Sirt3skm−/− mice subjected to HFD. (A) Protein expression levels of complex I, II, IV and V in isolated mitochondria of Sirt3skm+/+ and Sirt3skm−/− muscle (left panels) and Sirt3hep+/+ and Sirt3hep−/− livers (right panels). (B, C) Acetylation status of mitochondrial proteins extracted from muscle and liver of Sirt3skm+/+ and Sirt3skm−/− mice (B) and Sirt3hep+/+ and Sirt3hep−/− mice (C). Mitochondrial protein lysates were subjected to western blotting using an anti-acetylated lysine antibody (Ac-K) and porin as a loading control. (D) Acetylation level of complex I members (top two rows of panels) and Sod2 (bottom two rows of panels) in Sirt3skm+/+ and Sirt3skm−/− muscle (left panels) or Sirt3hep+/+ and Sirt3hep−/− livers (right panels). Endogenous Ndufa9 or Sod2 were immunopurified from muscle lysates and immunoblotted using Ndufa9/Sod2 and Ac-K antibodies. (E) Complex I (CI), complex IV (CIV) and Citrate synthase (CS) activities in Sirt3skm+/+ and Sirt3skm−/− muscle (left panel) or Sirt3hep+/+ and Sirt3hep−/− (right panel). (F) Oxygen consumption rate (OCR) from primary hepatocytes obtained from Sirt3L2/L2 mice infected with the indicated viruses. (G) ATP levels were measured from the indicated tissue lysates. (H–K) Activities of mitochondrial Sod2 (H) and catalase (I) and levels of 4-hydroxy-2-nonenal (HNE; J) and GSH/GSSG ratio (K) in muscle and liver lysates of Sirt3skm+/+ and Sirt3skm−/− mice (left panels) or Sirt3hep+/+ and Sirt3hep−/− mice (right panels). Measurements in panels E–K were determined using samples from at least four mice per genotype. All the samples used for these studies come from mice subjected to the HFD treatment, sacrificed in fed state. Data are represented as mean ± SEM.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 137

Metadata

Authors
Fernandez-Marcos, P. J., Jeninga, E. H., Canto, C., Harach, T., de Boer, V. C. J., Andreux, P., Moullan, N., Pirinen, E., Yamamoto, H., Houten, S. M., Schoonjans, K., & Auwerx, J.
Affiliations
  • École Polytechnique Fédérale de Lausanne (CH)
  • University of Eastern Finland (FI)
  • Amsterdam UMC Location University of Amsterdam (NL)
Corresponding author
Auwerx, Johan
Venue
Scientific Reports
Published
2012-05-28
Volume
2
Issue
1
Pages
425-425
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2022837727
Cited by
137
References
35
Citations by year
2026: 6 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 13 · 2020: 8 · 2019: 13 · 2018: 16 · 2017: 8 · 2016: 10 · 2015: 11 · 2014: 11 · 2013: 16 · 2012: 5
FWCI
6.75
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Socio-Environmental Systems Modeling (acceptedVersion, cc-by-nc-nd)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, cc-by-nc-nd)
Funders
  • National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A, 124713)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
SIRT3, mitochondrial sirtuins, protein hyperacetylation, mitochondrial proteins, muscle-specific knockout, liver-specific knockout, skeletal muscle, liver, metabolic homeostasis, oxidative stress, high-fat diet, mitochondrial dysfunction
MeSH terms
Superoxide Dismutase 2, Acetylation, Adenosine Triphosphate, Animals, Carnitine, Energy Metabolism, Female, Glutathione, Homeostasis, Liver, Male, Mice, Inbred C57BL, Mitochondria, Oxidation-Reduction, Superoxide Dismutase, Blotting, Western, Gene Expression, Reactive Oxygen Species, Mice, Knockout, Muscle, Skeletal, Reverse Transcriptase Polymerase Chain Reaction, Mitochondrial Proteins, Mice, Sirtuin 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.